Pharmaco - Press Releases

Date	Title	Company
21-Oct-2022	MPP signs licence agreement to increase access to nilotinib for the treatment of chronic myeloid leukaemia	Medicines Patent Pool
21-Oct-2022	Farmabios, Novasep and PharmaZell are now Axplora	Axplora
21-Oct-2022	Evolva receives grant from US CDC in the amount of USD 540,000	Evolva Holding SA
20-Oct-2022	IGEA Pharma N.V.: IGEA DISCLOSES ITS 2021 ANNUAL REPORT	IGEA Pharma N.V.
20-Oct-2022	Zur Rose Group announces results of Tender Offer	Zur Rose Group AG
20-Oct-2022	Committed to staying ahead with pioneering glass packaging solutions that answer the changing needs of the pharmaceutical industry, SGD Pharma is set to showcase its latest innovations at CPhI worldwide 2022	SGD Pharma
20-Oct-2022	Invitation: Straumann Group 2022 third-quarter financial results webcast	Straumann Holding AG
20-Oct-2022	Douglas GmbH: Sander van der Laan appointed as new DOUGLAS CEO – Tina Müller joins the Supervisory Board	Douglas GmbH
20-Oct-2022	Kancera reports promising preclinical results from studies of its Fractalkine axis blocking drug candidates in B-cell lymphoma	Kancera
20-Oct-2022	Chiesi and Aptar partner to bring to market Disease Management Platform for patients with asthma and COPD	Chiesi
20-Oct-2022	BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference	BD (Becton, Dickinson and Company)
20-Oct-2022	STORM Therapeutics to present new data on its lead program STC-15 at the 34th EORTC-NCI-AACR Symposium and the 37th SITC Meeting	STORM Therapeutics
20-Oct-2022	Beckman Coulter Life Sciences Proudly Presenting at American Society of Human Genetics Annual Meeting	Beckman Coulter Life Sciences
20-Oct-2022	BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI Worldwide 2022 Conference	B3C newswire
20-Oct-2022	First successful year on the market for Marinomed’s Solv4U technology partnerships	Marinomed Biotech AG
20-Oct-2022	After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022	Zur Rose Group AG
20-Oct-2022	Cosmo announces FDA grants orphan-drug designation of rifamycin for treatment of pouchitis	Cosmo Pharmaceuticals N.V.
19-Oct-2022	AEVIS VICTORIA SA – AEVS.SW – Repayment of the CHF 145 million bond issued on 17 October 2016	AEVIS VICTORIA SA
19-Oct-2022	Jazz Pharmaceuticals And Zymeworks Announce Exclusive License Agreement To Develop And Commercialize Zanidatamab, A HER2-Targeted Bispecific Antibody	Jazz Pharmaceuticals
19-Oct-2022	90-DAY ANALYSIS SHOWS MODERNA’S OMICRON BA.1-TARGETING BIVALENT VACCINE, mRNA-1273.214, DEMONSTRATES SUPERIOR ANTIBODY RESPONSE AS FOURTH BOOSTER COMPARED TO SPIKEVAX PROTOTYPE BOOSTER	Moderna, Inc.